SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that HLA-A24-restricted mammaglobin-A (Mam-A) derived CD8(+) cytotoxic T lymphocyte (CTL) epitopes that can potentially be employed for Mam-A-based breast cancer vaccine therapy to breast cancer patients with HLA-A24 phenotype."
xsd:string
http://purl.uniprot.org/uniprot/#_CAC93E6D0162922912CE3C109104D76BF50F801E71ED0807691561CC7D0F20E530469CE2384B3826DBCC530D8EB31F17
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF
http://purl.uniprot.org/uniprot/K7P4Y5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF
http://purl.uniprot.org/uniprot/#_K7P4Y5-mappedCitation-22074997
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/981678891CFE1E62958EF032D331DE081870397FF4161756D18A01030D6E36520F840E225D54025EE6886D41C33441BF